by nobilistx | Oct 22, 2020 | Uncategorized |
PORTLAND, Ore., October 22, 2020 – Nobilis Therapeutics announced today the issuance of a US Patent (US Patent No: 10,792,305 B2) for a patent titled “Therapeutic immune modulation using noble gas compositions.” One of it broadest claims includes “a method of treating...